We are experiencing a very high volume of calls and messages and ask for your patience. We will answer your portal messages within 48 hours.
Polycystic ovary syndrome (PCOS) is a common cause of infertility. Briefly, its diagnosis is based on presence of two of the following three criteria:
There is a wide variation in the clinical presentation of patients with PCOS. Obesity is not a criterion for diagnosing PCOS, although many PCOS patients are obese. In obese patients with PCOS, weight loss remains the best treatment.
With weight loss, many obese PCOS patients will start getting periods, start ovulating and even conceive naturally.
Insulin resistance (IR) is a common hormonal imbalance in patients with PCOS. IR is generally defined as ‘‘a state (of a cell, tissue, or organism) in which a greater than normal amount of insulin is required to elicit a quantitatively normal response’’ and maintain glucose levels within the normal range.
Individuals with IR may be overtly diabetic or merely have insulin resistance detected by testing. Your physician will check your blood sugar, and sometimes, insulin levels to diagnose IR.
Metformin (Glucophage) is an oral medication that is used to treat Type II diabetes. It is also used in PCOS patients to correct insulin resistance.
It comes in immediate release (500, 850 and 1,000 mg tablets) or extended release (Glucophage XR, 500, 750 and 1,000 mg tablets) form. Both are equally effective. The XR version is slowly absorbed and has fewer side effects (nausea, vomiting, diarrhea).
A rare side effect is lactic acidosis, which mainly occurs in patients with severe kidney and liver disease (your doctor will check you for these before starting metformin).
Metformin should be discontinued if you are going to need a CT scan or MRI that requires the use of an iodine-contrast agent. It can be restarted a couple of days after your scan. If you need to have an MRI or scan while being treated with metformin, make sure you tell your practitioner you are taking it.
The mechanism of action remains unclear, but it is known that metformin reduces absorption of glucose by the stomach and intestines, reduces glucose production by the liver, and increases insulin-stimulated glucose uptake.
Yes, it does. Many PCOS patients will start getting regular periods and start ovulating with metformin. Surprisingly, the pregnancy and live-birth rates are not better compared to placebo (dummy-pills)!
How does metformin compare with clomiphene citrate (CC, Clomid) or letrozole (Femara)?
Not well. The ovulation rate, pregnancy rate and live birth rate is lower with metformin alone when compared to CC or letrozole. These are two commonly used drugs used for ovulation induction in patients with PCOS. The pregnancy rate is best with letrozole, which is currently the drug of choice.
Yes, it can. Pretreatment with metformin for at least 3 months followed by the addition of another ovulation-inducing drug increases live-birth rate. Addition of metformin can also help in patients that are resistant to CC alone. Metformin alone does not increase the rate of multiple pregnancy.
Yes, it can. It is a Category B medication (no risk in non-human studies). If metformin is stopped at the initiation of pregnancy, it does not affect the rate of miscarriage. In patients with IR, metformin will reduce the incidence of diabetes in pregnancy.
Here is a summary:
At InVia Fertility Specialists, our board certified reproductive endocrinologists are experts in treating patients with PCOS. Please call 847-884-8884 to schedule an appointment at one of our four convenient Chicagoland locations.
Entire Website © 2003 - 2020
Karande and Associates d/b/a InVia
Fertility Specialists